Yuki Kageyama to Transfection
This is a "connection" page, showing publications Yuki Kageyama has written about Transfection.
Connection Strength
0.191
-
Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors. Prostate. 2007 Jun 01; 67(8):799-807.
Score: 0.061
-
CTLA4Ig-gene transfection with FTY720 administration markedly inhibits the obliterative airway disease in heterotopically transplanted rat tracheas. Transplant Proc. 2003 Feb; 35(1):458-60.
Score: 0.045
-
Development of a novel interferon-a2b gene construct with a repetitive hypoxia-inducible factor binding site and its suppressive effects on human renal cell carcinoma cell lines in vitro. Int J Clin Oncol. 2014; 19(3):497-504.
Score: 0.023
-
Time course of gene expression after the injection of adenoviral vectors containing CTLA4IG gene. Transplant Proc. 2004 Oct; 36(8):2443-5.
Score: 0.013
-
HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004 May 05; 23(9):1949-56.
Score: 0.012
-
Prolonged graft survival induced by CTLA4IG gene transfection in rat lung allografting. Transplant Proc. 2003 Feb; 35(1):456-7.
Score: 0.011
-
Combined therapy of CTLA4Ig-gene transfection with FTY720 administration in rat lung allografts. Transplant Proc. 2002 Aug; 34(5):1437-40.
Score: 0.011
-
Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma. Cancer. 2001 Apr 15; 91(8):1429-36.
Score: 0.010
-
Distinct downstream signaling mechanism between erythropoietin receptor and interleukin-2 receptor. EMBO J. 1992 Dec; 11(13):4909-15.
Score: 0.006